ArticleNature communications2024

PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial.

Mark N Stein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.